Plasma active vitamin D concentration in low birthweight infants with rickets and its response to vitamin D treatment. 1981

Y Seino, and T Ishii, and T Shimotsuji, and M Ishida, and H Yabuuchi

Impairment of 25-hydroxylation may be a cause of rickets in infants of low birthweight, weighing between 2000 and 2500 g. In addition there may be impairment of 1 alpha-hydroxylation in infants weighing less than 2000 g. Our data show that a supplementary dose of vitamin D2 of at least 500 IU daily is a reasonable regimen for infants who weighed between 2000 and 2500 g at birth. However for infants who weighed less than 2000 g with a gestation of under 38 weeks, administration of 1 alpha-OHD3 may be more effective in preventing rickets.

UI MeSH Term Description Entries
D007223 Infant A child between 1 and 23 months of age. Infants
D007230 Infant, Low Birth Weight An infant having a birth weight of 2500 gm. (5.5 lb.) or less but INFANT, VERY LOW BIRTH WEIGHT is available for infants having a birth weight of 1500 grams (3.3 lb.) or less. Low Birth Weight,Low-Birth-Weight Infant,Birth Weight, Low,Birth Weights, Low,Infant, Low-Birth-Weight,Infants, Low-Birth-Weight,Low Birth Weight Infant,Low Birth Weights,Low-Birth-Weight Infants
D007231 Infant, Newborn An infant during the first 28 days after birth. Neonate,Newborns,Infants, Newborn,Neonates,Newborn,Newborn Infant,Newborn Infants
D002117 Calcitriol The physiologically active form of vitamin D. It is formed primarily in the kidney by enzymatic hydroxylation of 25-hydroxycholecalciferol (CALCIFEDIOL). Its production is stimulated by low blood calcium levels and parathyroid hormone. Calcitriol increases intestinal absorption of calcium and phosphorus, and in concert with parathyroid hormone increases bone resorption. 1 alpha,25-Dihydroxycholecalciferol,1 alpha,25-Dihydroxyvitamin D3,1, 25-(OH)2D3,1,25(OH)2D3,1,25-Dihydroxycholecalciferol,1,25-Dihydroxyvitamin D3,1 alpha, 25-dihydroxy-20-epi-Vitamin D3,1,25(OH)2-20epi-D3,1,25-dihydroxy-20-epi-Vitamin D3,20-epi-1alpha,25-dihydroxycholecaliferol,Bocatriol,Calcijex,Calcitriol KyraMed,Calcitriol-Nefro,Decostriol,MC-1288,MC1288,Osteotriol,Renatriol,Rocaltrol,Silkis,Sitriol,Soltriol,Tirocal,1 alpha,25 Dihydroxyvitamin D3,1,25 Dihydroxycholecalciferol,1,25 Dihydroxyvitamin D3,1,25 dihydroxy 20 epi Vitamin D3,Calcitriol Nefro,D3, 1 alpha,25-Dihydroxyvitamin,D3, 1,25-Dihydroxyvitamin,D3, 1,25-dihydroxy-20-epi-Vitamin,KyraMed, Calcitriol,MC 1288
D004100 Dihydroxycholecalciferols Cholecalciferols substituted with two hydroxy groups in any position. Dihydroxyvitamins D
D004872 Ergocalciferols Derivatives of ERGOSTEROL formed by ULTRAVIOLET RAYS breaking of the C9-C10 bond. They differ from CHOLECALCIFEROL in having a double bond between C22 and C23 and a methyl group at C24. Calciferols,Vitamin D 2,Ergocalciferol,Vitamin D2,D2, Vitamin
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006887 Hydroxycholecalciferols Hydroxy analogs of vitamin D 3; (CHOLECALCIFEROL); including CALCIFEDIOL; CALCITRIOL; and 24,25-DIHYDROXYVITAMIN D 3. Hydroxyvitamins D,Hydroxycholecalciferol
D012279 Rickets Disorders caused by interruption of BONE MINERALIZATION manifesting as OSTEOMALACIA in adults and characteristic deformities in infancy and childhood due to disturbances in normal BONE FORMATION. The mineralization process may be interrupted by disruption of VITAMIN D; PHOSPHORUS; or CALCIUM homeostasis, resulting from dietary deficiencies, or acquired, or inherited metabolic, or hormonal disturbances. Rachitis,Rachitides
D015652 25-Hydroxyvitamin D 2 9,10-Secoergosta-5,7,10(19),22-tetraene-3,25-diol. Biologically active metabolite of vitamin D2 which is more active in curing rickets than its parent. The compound is believed to attach to the same receptor as vitamin D2 and 25-hydroxyvitamin D3. 25-Hydroxyergocalciferol,25-Hydroxycalciferol,25-Hydroxyvitamin D2,9,10-Secoergosta-5,7,10(19),22-tetraene-3 beta,25-diol,Ercalcidiol,25 Hydroxycalciferol,25 Hydroxyergocalciferol,25 Hydroxyvitamin D 2,25 Hydroxyvitamin D2

Related Publications

Y Seino, and T Ishii, and T Shimotsuji, and M Ishida, and H Yabuuchi
November 1982, Archives of disease in childhood,
Y Seino, and T Ishii, and T Shimotsuji, and M Ishida, and H Yabuuchi
August 1986, Archives of disease in childhood,
Y Seino, and T Ishii, and T Shimotsuji, and M Ishida, and H Yabuuchi
November 1986, Acta paediatrica Scandinavica,
Y Seino, and T Ishii, and T Shimotsuji, and M Ishida, and H Yabuuchi
May 1983, Archives of disease in childhood,
Y Seino, and T Ishii, and T Shimotsuji, and M Ishida, and H Yabuuchi
June 1983, Archives of disease in childhood,
Y Seino, and T Ishii, and T Shimotsuji, and M Ishida, and H Yabuuchi
December 1981, Australian paediatric journal,
Y Seino, and T Ishii, and T Shimotsuji, and M Ishida, and H Yabuuchi
January 1987, Pediatric radiology,
Y Seino, and T Ishii, and T Shimotsuji, and M Ishida, and H Yabuuchi
January 1985, Progress in clinical and biological research,
Y Seino, and T Ishii, and T Shimotsuji, and M Ishida, and H Yabuuchi
January 2009, Archives of disease in childhood. Fetal and neonatal edition,
Y Seino, and T Ishii, and T Shimotsuji, and M Ishida, and H Yabuuchi
September 1982, Polski tygodnik lekarski (Warsaw, Poland : 1960),
Copied contents to your clipboard!